Saatci, O. Et Al. 2023. Targeting TACC3 represents a novel vulnerability in highly aggressive breast cancers with centrosome amplification. Cell Death and Differentiation , vol.30, no.5 , 1305-1319.

Saatci, O., Akbulut, O., Cetin, M., Sikirzhytski, V., ÜNER, M., LENGERLİ, D., ... O’Quinn, E. C.(2023). Targeting TACC3 represents a novel vulnerability in highly aggressive breast cancers with centrosome amplification. Cell Death and Differentiation , vol.30, no.5, 1305-1319.

Saatci, Ozge Et Al. "Targeting TACC3 represents a novel vulnerability in highly aggressive breast cancers with centrosome amplification," Cell Death and Differentiation , vol.30, no.5, 1305-1319, 2023

Saatci, Ozge Et Al. "Targeting TACC3 represents a novel vulnerability in highly aggressive breast cancers with centrosome amplification." Cell Death and Differentiation , vol.30, no.5, pp.1305-1319, 2023

Saatci, O. Et Al. (2023) . "Targeting TACC3 represents a novel vulnerability in highly aggressive breast cancers with centrosome amplification." Cell Death and Differentiation , vol.30, no.5, pp.1305-1319.

@article{article, author={Ozge Saatci Et Al. }, title={Targeting TACC3 represents a novel vulnerability in highly aggressive breast cancers with centrosome amplification}, journal={Cell Death and Differentiation}, year=2023, pages={1305-1319} }